Hier nun die Aufklärung rundum um das Thema Fujifilm Teeside und der UK Zulassung:
The concern followed public statements from Novavax’s head of corporate affairs which cast doubt on the situation.
Silvia Taylor told reporters the first batches would be shipped from India in March.
Mr Cunningham told Teesside on Friday that the confusion has now been cleared up.
He said: "Following 36 hours of total confusion - including in the media - whether the Novavax vaccine would be produced in Billingham, I sought clarification and have now spoken to a representative of Fujifilm who has confirmed that Novavax has assured them that production will take place at this site."
Initial supplies of the vaccine will be imported from the Serum Institute of India (SII), said Novavax.
"This is because we harmonized our initial regulatory filings using manufacturing data from SII as the most expeditious path to authorisation," said a Novavax spokesperson.
"The CMA will later be supplemented with data from additional manufacturing sites in the Novavax global supply chain. This approach in the UK is consistent with our approach in other markets across the world."
Novavax said it continues to “work closely” with Fujifilm on supply of the vaccine.
“While we don’t disclose the specifics of our agreements with manufacturers, we can share that we continue to work closely with Fujifilm Diosynth Biotechnologies and the VTF on manufacturing and supply of the Novavax vaccine in the UK and FDB continues to be an important partner," said the spokesperspom.
Previously, the Prime Minister described the work being done at the Billingham site on the jab as "some of the very best of British science and manufacturing."
Fujifilm said they continue to "work closely" with Novavax and the Vaccines Taskforce on the manufacturing and supply of the vaccine in the UK.
"We have been manufacturing on Teesside since February 2021 – and continue to work hard to support Novavax to advance the manufacturing and supply of Nuvaxovid for patients," said a spokesperson.
“Everyone at Fujifilm Diosynth Biotechnologies is delighted that the UK’s Medicines and Healthcare products Regulatory Agency has approved the Novavax vaccine. We are all immensely proud to be part of this endeavour.”
Mr Cunningham said: "I’m pleased this has been cleared up, and done so promptly, and look forward to seeing vaccines produced in Billingham and protecting people as quickly as possible.”
www.google.com/amp/s/...-5bZQ_YRk4Mu8KRDF-pcoeu0Qis-e_SiPe-ts
Zurück
